Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C R M Hay

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Pathophysiology of Haemostasis and Thrombosis|September 6, 2002
The 2000 United Kingdom Haemophilia Centre Doctors' Organisation (UKHCDO) inhibitor guidelinesC R M Hay,
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 22, 2007
Prophylaxis in adults with haemophiliaC R M Hay
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 8, 2002
Porcine factor VIII: current status and future developmentsC R M Hay
Journal of Thrombosis and Haemostasis : JTH|October 1, 2004
Thrombosis and recombinant factor VIIaC R M Hay
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 29, 2013
Purchasing factor concentrates in the 21st century through competitive tenderingC R M Hay
Journal of Thrombosis and Haemostasis : JTH|July 20, 2006
The international immune tolerance study: a multicenter prospective randomized trial in progressD M Dimichele, C R M Hay
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 28, 2016
Use of the UKHCDO Database for a postmarketing surveillance study of different doses of recombinant factor VIIa in haemophiliaC R M Hay, T Sharpe, G Dolan, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 5, 2013
Tamoxifen for recurrent bleeds due to angiodysplasia in von Willebrand's diseaseJ Thachil, C R M Hay, S Campbell
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 26, 2012
How I treat inhibitors in haemophiliaM Makris, C R M Hay, A Gringeri, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 19, 2017
Weekly recombinant FIX prophylaxis for severe haemophilia B in normal clinical practice: data from UKHCDO and FinlandM Scott, V Nummi, R Lassila, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Pathophysiology of Haemostasis and Thrombosis|September 6, 2002
The 2000 United Kingdom Haemophilia Centre Doctors' Organisation (UKHCDO) inhibitor guidelinesC R M Hay,
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 22, 2007
Prophylaxis in adults with haemophiliaC R M Hay
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 8, 2002
Porcine factor VIII: current status and future developmentsC R M Hay
Journal of Thrombosis and Haemostasis : JTH|October 1, 2004
Thrombosis and recombinant factor VIIaC R M Hay
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 29, 2013
Purchasing factor concentrates in the 21st century through competitive tenderingC R M Hay
Journal of Thrombosis and Haemostasis : JTH|July 20, 2006
The international immune tolerance study: a multicenter prospective randomized trial in progressD M Dimichele, C R M Hay
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 28, 2016
Use of the UKHCDO Database for a postmarketing surveillance study of different doses of recombinant factor VIIa in haemophiliaC R M Hay, T Sharpe, G Dolan, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 5, 2013
Tamoxifen for recurrent bleeds due to angiodysplasia in von Willebrand's diseaseJ Thachil, C R M Hay, S Campbell
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 26, 2012
How I treat inhibitors in haemophiliaM Makris, C R M Hay, A Gringeri, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 19, 2017
Weekly recombinant FIX prophylaxis for severe haemophilia B in normal clinical practice: data from UKHCDO and FinlandM Scott, V Nummi, R Lassila, et al.
Pageof 4